Science Applications International Corp (SAIC) stock analysis
Close on Nov 11, 2026Market cap $6.39BP/E –Yield 0.97%
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed11 of 30 checks passed
Science Applications International passes 11 of the 30 checks behind our score; 10 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 1/6
- Growth
- 3/6
- Past performance
- 1/6
- Financial health
- 3/6
- Dividend
- 3/6
What stands out
Trading below fair value
The share price of $152.57 is below our fair value estimate of $165.57.
Return on capital over 10%
Return on invested capital was 13.0%, above the 10% that usually covers the cost of capital.
EPS growing 10%+ a year
Diluted EPS grew 12.7% a year over the last three fiscal years.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 26.6% of total debt.
What to watch
Margin of safety under 20%
The price is 7.9% below fair value, less than the 20% cushion we look for.
High debt
Debt is 173% of shareholders' equity, above the 40% we consider low.
Revenue growing under 10% a year
Revenue grew -2.0% a year over the last three fiscal years, short of the 10% we look for.
EV/EBITDA above its 5-year median
Science Applications International's EV/EBITDA of 13.9 is above its 5-year median of 13.4.
Valuation1/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
EV/EBITDA above its 5-year median
Science Applications International's EV/EBITDA of 13.9 is above its 5-year median of 13.4.
P/B above the industry
Science Applications International's price-to-book of 4.45 is above the Computer Programming, Data Processing, and Other Computer Related Services median of 3.32.
Trading below fair value
The share price of $152.57 is below our fair value estimate of $165.57.
Margin of safety under 20%
The price is 7.9% below fair value, less than the 20% cushion we look for.
Growth3/6
Revenue growing under 10% a year
Revenue grew -2.0% a year over the last three fiscal years, short of the 10% we look for.
EPS growing 10%+ a year
Diluted EPS grew 12.7% a year over the last three fiscal years.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing slower than the industry
Revenue grew -0.8% over the last twelve months; the Computer Programming, Data Processing, and Other Computer Related Services median is 9.6%.
Guidance raised
Science Applications International raised its Fiscal Year 2027 Guidance Organic Growth outlook on Aug 31, 2026.
Gross margin improving
Gross margin was 12.6% over the last twelve months, against 12.0% a year earlier.
Past performance1/6
Return on equity
Needs positive equity and five years of results.
Return on capital over 10%
Return on invested capital was 13.0%, above the 10% that usually covers the cost of capital.
Return on equity against the industry
Needs positive equity.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin against its history
Needs five years of revenue and net income.
Net margin against the industry
Needs revenue and net income.
Financial health3/6
High debt
Debt is 173% of shareholders' equity, above the 40% we consider low.
Debt rising against equity
Debt to equity rose from 163% five years ago to 173%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 26.6% of total debt.
Interest coverage
Interest expense is not reported separately.
Short-term assets cover short-term debts
Current assets are 1.20 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 3.10; above 3 is the safe zone and below 1.8 the distress zone.
Dividend3/6
Pays a dividend
Science Applications International paid dividends worth 1.0% of the share price over the last twelve months.
Yield below Treasuries
The 1.0% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Science Applications International yields 1.0%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Earnings cover
Needs dividends paid and net income.
Covered by free cash flow
Dividends take 10.8% of free cash flow.
Fair value
How we estimate itOur estimate per share
$165.57
The share price is 8% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| EV/EBITDA | 16.1× | 13.4× | 18.8× | $185.48 | 58% |
| P/B | 3.4× | 3.4× | 3.3× | $114.93 | 17% |
| Earnings power | 7.4% cost of equity | – | – | $152.87 | 25% |
| Fair value | $165.57 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 16.9
- Computer Programming, Data Processing, and Other Computer Related Services median 27.6
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $60.06M
- Value traded per 1% price move
- $45.32M
Downside
Medium risk
- Typical loss in a bad month
- 19.6%
- Volatility (annualized)
- 39%
- Sharpe ratio, 1 year
- 1.57
- Beta to the S&P 500 (5Y)
- 0.48
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2012 to 2026
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2026
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -2.9% | -2.0% | +0.6% | +5.3% | |
| Gross profit | -2.2% | -0.6% | +1.9% | +7.8% | |
| Operating income | -7.5% | +1.3% | +6.0% | +8.7% | |
| EPS, diluted | +7.4% | +12.7% | +16.7% | +12.0% | |
| Free cash flow | +26.0% | +4.4% | -4.0% | +10.8% | |
| Dividend per share | 0.0% | 0.0% | 0.0% | +2.0% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2021 | FY2026 | Trend |
|---|---|---|---|---|
| Return on equity | 39.2% | 14.1% | – | |
| Return on assets | 6.9% | 4.0% | – | |
| Current ratio | 1.45 | 1.01 | 1.20 | |
| Debt to equity | 3.00 | 1.63 | 1.66 | |
| Net debt to EBITDA | 2.90× | 5.51× | 4.18× | |
| Interest coverage | 5.1× | 3.2× | – | |
| Inventory turnover | 57.6× | 77.3× | – | |
| Capex to revenue | 0.3% | 0.7% | 0.4% | |
| Diluted shares | 46M | 59M | 47M |
Where the cash went
Fiscal 2022 to 2026, five years combined
Science Applications International generated $2.55B from operations and spent $2.43B on capital expenditure, dividends and share buybacks. 6% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 4.8% | 1.42× | 3.14× | 21.5% |
| FY2024 | 6.4% | 1.37× | 3.12× | 27.4% |
| FY2023 | 3.9% | 1.36× | 3.41× | 18.1% |
| FY2022 | 3.7% | 1.29× | 3.63× | 17.5% |
| FY2021 | 3.0% | 1.35× | 3.53× | 14.1% |
| FY2020 | 3.5% | 1.38× | 3.20× | 15.6% |
| FY2019 | 2.9% | 1.40× | 3.66× | 15.1% |
| FY2018 | 4.0% | 2.16× | 6.09× | 53.0% |
| FY2017 | 3.2% | 2.13× | 5.71× | 39.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2026 against fiscal 2025
- ProfitableNet income above zero–
- Cash generatingOperating cash flow above zero$609.00M
- Return on assets improvedROA up on the prior year6.8% → –
- Earnings backed by cashOperating cash flow above net income$609.00M vs –
- Less leverageLong-term debt to assets fell36.4% → 46.1%
- Better liquidityCurrent ratio rose0.83 → 1.20
- No dilutionShare count did not rise51M → 47M
- Gross margin improvedGross margin up on the prior year11.93% → 12.01%
- More efficientAsset turnover rose1.41 → 1.38
See a number that looks wrong?